The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking

Abstract

Background Interstitial lung disease (ILD) is associated with substantial morbidity and mortality, which is one of the key systematic manifestations of connective tissue disease (CTD). Tripterygium wilfordii, known as Leigongteng in Chinese, has been applied to treat connective tissue disease-related interstitial lung disease (CTD-ILD) for many years. Triptolide is a key effective component from Tripterygium wilfordii. But the molecular mechanism of Triptolide for treating CTD-ILD is not yet clear. Methods Gaining insight into the molecular mechanism of Triptolide intervention CTD-ILD, we used the method of network pharmacology. And then we conducted drug-target networks to analyse the potential protein targets between Triptolide and CTD-ILD. Finally, AutoDock Vina was selected for molecular docking. Results By analysing the interaction genes between Triptolide and CTD-ILD, 242 genes were obtained. The top 10 targets of the highest enrichment scores were STAT3, AKT1, MAPK1, IL6, TP53, MAPK3, RELA, TNF, JUN, JAK2. GO and KEGG enrichment analysis exhibited that multiple signalling pathways were involved. PI3K-Akt, multiple virus infections, cancer signalling, chemokine, and apoptosis signalling pathway are the main pathways for Triptolide intervention CTD-ILD. And it is related to various biological processes such as inflammation, infection, cell apoptosis, and cancer. Molecular docking shows Triptolide can bind with its target protein in a good bond by intermolecular force. Conclusions This study preliminarily reveals the internal molecular mechanism of Triptolide interfere with CTD-ILD through multiple targets, multiple access, validated through molecular docking. KEY MESSAGES Triptolide intervention CTD-ILD, which are related to various biological processes such as inflammation, infection, cell apoptosis, and cancer. PI3K-Akt, multiple virus infections, and apoptosis signalling pathway are the main pathways for Triptolide intervention CTD-ILD. Triptolide can bind with related target protein in a good bond by Intermolecular force, exhibiting a good docking activity.

Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis

“…A binding energy of <−5 kcal/mol is generally considered indicative of good binding activity and affinity. [31,32] Our molecular docking results reveal that the compounds we screened have high affinity with the core target, as their binding energies are all <−5 kcal/mol. The specific docking energies can be found in Table 2.…”

Global Downregulation of Penicillin Resistance and Biofilm Formation by MRSA Is Associated with the Interaction between Kaempferol Rhamnosides and Quercetin

“…Molecular docking ( 57 ) was performed to assess the affinity of interaction between compounds identified from CAEs and the IcaA, AgrA, RNAIII, SarA, LuxS, FnbA, FnbB, ClfA, ClfB, EbpS, CidA, LrgA, SspA, Psm, AtlA, Hld, Vwb, and Coa proteins. Crystallographic structures of the selected proteins were downloaded from RCSB Protein Data Bank ( https://www.rcsb.org/ ) with their native ligands.…”

Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease

“…The Canonical Smiles of active ingredient were entered into the SwissTargetPrediction database (http://www.swisstargetprediction. ch/), and the species was defined as "homo sapiens", followed by a probability > 0 screening (Zhu et al, 2022). It was merged with the predicted targets of the TCMSP database corrected by the UniProt database (https://www.uniprot.org), and the target genes of the MFO's active components were obtained after deduplication.…”